Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 12, Issue 2, Pages 89-94
http://dx.doi.org/10.1080/0962933031000097691

Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1β and IL-1ra production in multiple sclerosis

1Department of Neurology, Vrije Universiteit Medical Centre, P.O. Box 7057, Amsterdam 1007 MB, The Netherlands
2Department of Cell Biology and Immunology, Vrije Universiteit Medical Centre, Van der Boechorststraat 7, Amsterdam 1081 BT, The Netherlands
3Department of Gastroenterology and Lab for Gastrointestinal Immunogenetics, Vrije Universiteit Medical Centre, Van der Boechorststraat 7, Amsterdam 1081 BT, The Netherlands
4Department of Epidemiology and Biostatistics, Vrije Universiteit Medical Centre, Van der Boechorststraat 7, Amsterdam 1081 BT, The Netherlands

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [27 citations]

The following is the list of published articles that have cited the current article.

  • Jian Hong, Ying C.Q Zang, George Hutton, Victor M Rivera, and Jingwu Z Zhang, “Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis,” Journal of Neuroimmunology, vol. 152, no. 1-2, pp. 126–139, 2004. View at Publisher · View at Google Scholar
  • J Imitola, T Chitnis, and Sj Khoury, “Cytokines in multiple sclerosis: from bench to bedside,” Pharmacology & Therapeutics, vol. 106, no. 2, pp. 163–177, 2005. View at Publisher · View at Google Scholar
  • F Graziano, A Ruzzo, D Santini, B Humar, G Tonini, V Catalano, R Berardi, F Pizzagalli, F Arduini, I Bearzi, M Scartozzi, S Cascinu, E Testa, R Ficarelli, and M Magnani, “Prognostic role of interleukin-1 beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer,” Journal Of Clinical Oncology, vol. 23, no. 10, pp. 2339–2345, 2005. View at Publisher · View at Google Scholar
  • Helge Lind, Shanbeh Zienolddiny, David Ryberg, Vidar Skaug, David H. Phillips, and Aage Haugen, “Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: A possible interaction with polymorphisms in the interleukin 1 beta gene,” Lung Cancer, vol. 50, no. 3, pp. 285–290, 2005. View at Publisher · View at Google Scholar
  • Evica Dincic, Maja Živkovic, Aleksandra Stankovic, Dragana Obradovic, Dragan Alavantic, Vladimir Kostic, and Ranko Raicevic, “Association of polymorphisms in CTLA-4, IL-1ra and IL-1β genes with multiple sclerosis in Serbian population,” Journal of Neuroimmunology, vol. 177, no. 1-2, pp. 146–150, 2006. View at Publisher · View at Google Scholar
  • Monika Buraczynska, Piotr Ksiazek, Piotr Kubit, and Wojciech Zaluska, “Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure,” Cytokine, vol. 36, no. 3-4, pp. 167–172, 2006. View at Publisher · View at Google Scholar
  • Alastair Compston, Ian McDonald, David Miller, Kenneth Smith, Hartmut Wekerle, Christian Confavreux, John Noseworthy, and Hans Lassmann2006. View at Publisher · View at Google Scholar
  • Sumeet Agrawal, Rajni Srivastava, Banwari Sharma, Sapan Pandya, Ramnath Misra, and Amita Aggarwal, “IL1RN*2 allele of IL-1receptor antagonist VNTR polymorphism is associated with susceptibility to anklyosing spondylitis in Indian patients,” Clinical Rheumatology, vol. 27, no. 5, pp. 573–576, 2007. View at Publisher · View at Google Scholar
  • Yoko Warabi, “Role of IL-1 and potential therapies in multiple sclerosis,” Drug Discovery Today: Therapeutic Strategies, vol. 4, no. 1, pp. 19–24, 2007. View at Publisher · View at Google Scholar
  • E. Lahner, V. D. Corleto, G. D’Ambra, E. Di Giulio, G. Delle Fave, and B. Annibale, “Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?,” Alimentary Pharmacology & Therapeutics, vol. 27, no. 4, pp. 355–365, 2007. View at Publisher · View at Google Scholar
  • Roberto Roiz-Santiáñez, Benedicto Crespo-Facorro, Rocío Pérez-Iglesias, José María Pelayo-Terán, Eugenio Carrasco-Marín, Ignacio Mata, Elena Sánchez, Francisco Leyva-Cobián, and José Luis Vázquez-Barquero, “Interleukin-1 receptor antagonist genotype and brain morphometry in first-episode non-affective psychosis,” Psychiatry Research: Neuroimaging, vol. 162, no. 2, pp. 167–171, 2008. View at Publisher · View at Google Scholar
  • F Graziano, A Ruzzo, E Canestrari, F Loupakis, D Santini, E Rulli, B Humar, N Galluccio, R Bisonni, I Floriani, P Maltese, A Falcone, G Tonini, V Catalano, A Fontana, L Giustini, G Masi, B Vincenzi, P Alessandroni, and M Magnani, “Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer,” The Pharmacogenomics Journal, vol. 9, no. 1, pp. 78–84, 2008. View at Publisher · View at Google Scholar
  • Andrew Gordon, E. Kiss-Toth, Ian Stockley, Richard Eastell, and J. Mark Wilkinson, “Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty,” Arthritis & Rheumatism, vol. 58, no. 10, pp. 3157–3165, 2008. View at Publisher · View at Google Scholar
  • Irena Dujmovic, Katia Mangano, Tatjana Pekmezovic, Cinzia Quattrocchi, Sarlota Mesaros, Nebojsa Stojsavljevic, Ferdinando Nicoletti, and Jelena Drulovic, “The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy,” Journal of Neuroimmunology, vol. 207, no. 1-2, pp. 101–106, 2009. View at Publisher · View at Google Scholar
  • F. Hayashi, M. Watanabe, T. Nanba, N. Inoue, T. Akamizu, and Y. Iwatani, “Association of the −31C/T functional polymorphism in the interleukin-1β gene with the intractability of Graves' disease and the proportion of T helper type 17 cells,” Clinical & Experimental Immunology, vol. 158, no. 3, pp. 281–286, 2009. View at Publisher · View at Google Scholar
  • Brian Weinshenker, and Orhun Kantarci, “Multiple Sclerosis,” Cytokine Gene Polymorphisms in Multifactorial Conditions, pp. 289–304, 2009. View at Publisher · View at Google Scholar
  • María A. García-González, María A. Pérez Aísa, Mark Strunk, Rafael Benito, Elena Piazuelo, Pilar Jiménez, Federico Sopeña, and Angel Lanas, “Relevance of IL-1 and TNF gene polymorphisms on interleukin-1β and tumor necrosis factor-α gastric mucosal production,” Human Immunology, vol. 70, no. 11, pp. 935–945, 2009. View at Publisher · View at Google Scholar
  • I. Borzani, M. R. Tola, L. Caniatti, A. Collins, G. De Santis, D. Luiselli, E. Mamolini, and C. Scapoli, “The interleukin-1 cluster gene region is associated with multiple sclerosis in an Italian Caucasian population,” European Journal of Neurology, vol. 17, no. 7, pp. 930–938, 2010. View at Publisher · View at Google Scholar
  • T. Tuller, S. Atar, E. Ruppin, M. Gurevich, and A. Achiron, “Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions,” Human Molecular Genetics, vol. 20, no. 18, pp. 3606–3619, 2011. View at Publisher · View at Google Scholar
  • Nihal Isik, Ahmet Arman, Ilknur Aydin Canturk, Ajda Coker Gurkan, Fatma Candan, Sule Aktan, Nilufer Erzaim, Ozge Arici Duz, Tugrul Aydin, Muzaffer Turkes, and Edward O. List, “Multiple sclerosis: association with the interleukin-1 gene family polymorphisms in the Turkish population,” International Journal of Neuroscience, pp. 130507040221004, 2013. View at Publisher · View at Google Scholar
  • Masoumeh Heidary, Nahid Rakhshi, Majid Pahlevan Kakhki, Mehrdad Behmanesh, Mohammad Hossein Sanati, Nima Sanadgol, Hossein kamaladini, and Abbas Nikravesh, “The Analysis of Correlation between IL-1B Gene Expression and Genotyping in Multiple Sclerosis Patients,” Journal of the Neurological Sciences, 2014. View at Publisher · View at Google Scholar
  • Ayyoob Khosravi, Bita Javan, Mohammad Amin Tabatabaiefar, Hamid Ebadi, Davood Fathi, and Majid Shahbazi, “Association of interleukin-1 gene cluster polymorphisms and haplotypes with multiple sclerosis in an Iranian population,” Journal of Neuroimmunology, 2015. View at Publisher · View at Google Scholar
  • José-Noel Ibrahim, Eliane Chouery, Jean-Claude Lecron, André Mégarbané, and Myrna Medlej-Hashim, “Study of the association of IL-1β and IL-1RA gene polymorphisms with occurrence and severity of Familial Mediterranean fever,” European Journal of Medical Genetics, 2015. View at Publisher · View at Google Scholar
  • Moudi AL-Nashmi, Safa Taha, Isa Alsharoqi, and Moiz Bakhiet, “Interleukin 1 receptor antagonist and 2'−5'-oligoadenylate synthetase-like molecules as novel biomarkers for Multiple Sclerosis patients in Bahrain,” Multiple Sclerosis and Related Disorders, 2017. View at Publisher · View at Google Scholar
  • Monika Pandey, Shally Awasthi, and Mradula Chauhan, “Interplay of cytokines in preterm birth,” Indian Journal of Medical Research, vol. 146, no. September, pp. 316–327, 2017. View at Publisher · View at Google Scholar
  • Tomoyo Mizuma, Mikio Watanabe, Naoya Inoue, Yuya Arakawa, Saki Tomari, Yoh Hidaka, and Yoshinori Iwatani, “Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease,” Autoimmunity, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Maja Živković, Ivana Kolić, Snežana Jesić, Ana Jotić, and Aleksandra Stanković, “The Allele 2 of the VNTR Polymorphism in the Gene That Encodes a Natural Inhibitor of IL-1β, IL-1RA Is Favorably Associated With Chronic Otitis Media,” Clinical and Experimental Otorhinolaryngology, vol. 11, no. 2, pp. 118–123, 2018. View at Publisher · View at Google Scholar